Seniors with untreated hearing loss have greater risk of dementia, falls, hospitalization
By
Lois A. Bowers
Nov 12, 2018
Older adults with untreated hearing loss have a greater risk of dementia, depression, falls, hospitalization, rehospitalization and ER visits, according to newly published research.
Court’s labor ruling averts possible catastrophe
By
John O'Connor
Jul 07, 2016
A recent labor law ruling by Virginia’s highest court should have most senior living operators breathing a bit easier. That’s because an alternate decision could have launched a mountain of...
Employers can comment on ‘joint employer’ standard by summer, NLRB chairman says
By
Lois A. Bowers
Jun 07, 2018
The National Labor Relations Board expects to issue a notice of proposed rulemaking no later than this summer regarding the standard for determining joint-employer status, the agency’s chairman said...
62 symptoms linked to SARS-CoV-2 infection after 12 weeks
Jul 28, 2022
The highest adjusted hazard ratios were seen for anosmia, hair loss, sneezing, ejaculation difficulty and reduced libido.
SARS-CoV-2 infection cuts risk for reinfection for up to 10 months
Jun 15, 2021
The risk for PCR-positive infection higher for residents and staff members of long-term care facilities who were antibody-negative at baseline.
Signs/symptoms may ID COVID-19 even with negative RT-PCR
Feb 24, 2022
Patients who repeatedly tested negative but had signs/symptoms of COVID-19 had similar seroprevalence as RT-PCR-confirmed cases.
Two doses of mRNA-1273 effective against SARS-CoV-2 variants
Dec 15, 2021
Vaccine effectiveness against infection with delta variant declines with increasing time since vaccination.
Odds of SARS-CoV-2 infection down after third BNT162b2 dose
Dec 03, 2021
The estimated odds ratio of 0.14 at 28 to 65 days after receipt of the Pfizer-BioNTech booster was compared with those who received two doses.
Third BNT162b2 vaccine dose may cut severe COVID-19 outcomes
Nov 05, 2021
Fewer hospital admissions, cases of severe disease and COVID-19-related deaths were seen with the third dose of the Pfizer-BioNTech vaccine versus two doses received five months ago.
Allergy history may up risk for reactions to mRNA COVID-19 vaccine
Nov 04, 2021
The risk for allergic reactions within three days of vaccination is higher for those with history of high-risk allergy, but most completed the two-dose regimen. The mRNA vaccines approved for use against...